{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:13:21Z","timestamp":1778836401074,"version":"3.51.4"},"reference-count":15,"publisher":"Index Copernicus","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Otolaryngol Pol"],"published-print":{"date-parts":[[2026,3,20]]},"abstract":"<b>Introduction:<\/b> The ninth edition of the American Joint Committee on Cancer\/Union for International Cancer Control (AJCC\/UICC) tumor-node-metastasis (TNM) system for patients with non-metastatic nasopharyngeal carcinoma (NPC) was based on data from endemic regions, and it required validation for application to non-endemic regions. <br><br><b>Aim:<\/b> The aim of this study was to compare the performance of the 8<sup>th<\/sup> and the 9<sup>th<\/sup> editions of the AJCC\/UICC TNM system for patients with non-metastatic NPC from non-endemic regions. <br><br><b>Materials and methods:<\/b> Using the Surveillance, Epidemiology, and End Results (SEER) database, 2004\u20132021, we re-classified NPC patients using 8<sup>th<\/sup> and the 9<sup>th<\/sup> edition staging based on surrogate markers of advanced radiological extranodal extension (nodes described as \u201cfixed\u201d) and compared the prediction performance of both staging editions for overall survival (OS) and cancer specific survival (CSS). <br><br><b>Results:<\/b> Our analysis included 4981 patients with a median follow-up of 99.0 months. Comparing the 9<sup>th<\/sup> version of AJCC\/UICC (TNM-9) with TNM-8, only 29 (1.8%) patients with N1 and 47 (3.3%) patients with N2 were upstaged to N3 in TNM-9. In comparisons based on OS, TNM-9 did not outperform TNM-8 with regard to hazard consistency (2.2326 <i>vs<\/i> 1.9160), hazard discrimination (1.4092 <i>vs<\/i> 1.0947), sample size balance (0.3476 <i>vs<\/i> 0.3398), and percent variance explained (0.2704 <i>vs<\/i> 0.2704). The area under the receiver operating characteristic curve (AUC) values of TNM-9 and TNM-8 were 0.5299 and 0.5330 for OS (P = 0.549), respectively. The AUC values of TNM-9 and TNM-8 were 0.5332 and 0.5357 for CSS (P = 0.345), respectively. <br><br><b>Conclusions:<\/b> Restaging according to TNM-9 criteria involved only minor changes in the distribution of nodal (N) categories. Neither the TNM-9 nor the TNM-8 staging system demonstrated adequate overall discrimination between each stage group classification in terms of OS and CSS for patients with non-metastatic NPC from a non-endemic region.<\/ns3:p>","DOI":"10.5604\/01.3001.0055.6383","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T10:53:51Z","timestamp":1776941631000},"page":"23-30","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of the eighth and ninth editions of American Joint Committee on Cancer\/Union for International Cancer Control staging for non-metastatic nasopharyngeal carcinoma"],"prefix":"10.5604","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5882-0982","authenticated-orcid":false,"given":"Guoping","family":"Cheng","sequence":"first","affiliation":[{"name":"Department of Pathology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9897-0533","authenticated-orcid":false,"given":"Xiuzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Medical Technology, Kangda College of Nanjing Medical University, Lianyungang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4813-4274","authenticated-orcid":false,"given":"Yuting","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China, Postgraduate training base Alliance of Wenzhou Medical University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3394-4435","authenticated-orcid":false,"given":"Binhao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China, Postgraduate training base Alliance of Wenzhou Medical University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3741-6649","authenticated-orcid":false,"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China, Postgraduate training base Alliance of Wenzhou Medical University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6877-9042","authenticated-orcid":false,"given":"Xiaozhong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China, Postgraduate training base Alliance of Wenzhou Medical University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2803-0864","authenticated-orcid":false,"given":"Caineng","family":"Cao","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, China, Key Laboratory of Head & Neck Cancer Translational Research of Zhejiang Province, Hangzhou, Zhejiang, China, Postgraduate training base Alliance of Wenzhou Medical University, Hangzhou, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3689","reference":[{"key":"637131r1","doi-asserted-by":"crossref","unstructured":"Siak P.Y., Heng W.S., Teoh S.S.H., Lwin Y.Y., Cheah S.C.: Precision medicinein nasopharyngeal carcinoma: comprehensive review of past, present,and future prospect. J Transl Med., 2023; 21(1): 786. doi: 10.1186\/s12967-023-04673-8.","DOI":"10.1186\/s12967-023-04673-8"},{"key":"637131r2","doi-asserted-by":"crossref","unstructured":"Yacoub I., Qian J.Y., Nashed K. et al.: Radiation techniques and advancementsin nasopharyngeal carcinoma. Oral Oncol., 2024; 159: 107060. doi: 10.1016\/j.oraloncology.2024.107060.","DOI":"10.1016\/j.oraloncology.2024.107060"},{"key":"637131r3","doi-asserted-by":"crossref","unstructured":"Pan J.J., Mai H.Q., Ng W.T. et al.: Ninth version of the AJCC and UICC nasopharyngealcancer TNM staging classification. JAMA Oncol., 2024; 10(12):1627\u20131635. doi: 10.1001\/jamaoncol.2024.4354.","DOI":"10.1001\/jamaoncol.2024.4201"},{"key":"637131r4","doi-asserted-by":"crossref","unstructured":"Luo J., Hu X., Ge X.: Conditional survival nomogram for monitoring real-time survival of young non-metastatic nasopharyngeal cancer survivors.J Cancer Res Clin Oncol., 2023; 149(12): 10181\u201310188. doi: 10.1007\/s00432-023-04952-3.","DOI":"10.1007\/s00432-023-04952-3"},{"key":"637131r5","unstructured":"AJCC cancer staging manual, Eds.: M.B. Amin, S.B. Edge, F.L. Greene et al.Springer, New York 2017."},{"key":"637131r6","unstructured":"Union for international cancer control (UICC). TNM classification of malignanttumours, Eds.: J.D. Brierley, M.K. Gospodarowicz, C. Wittekind. Wiley-Blackwell, Chichester 2017."},{"key":"637131r7","doi-asserted-by":"crossref","unstructured":"Groome P.A., Schulze K., Boysen M., Hall S.F., Mackillop W.J.: A comparisonof published head and neck stage groupings in carcinomas of the oral cavity.Head Neck., 2001; 23(8): 613\u2013624. doi: 10.1002\/hed.1087.","DOI":"10.1002\/hed.1087"},{"key":"637131r8","doi-asserted-by":"crossref","unstructured":"Xie Y., Luo X., Li H. et al.: autoRPA: A web server for constructing cancer stagingmodels by recursive partitioning analysis. Comput Struct Biotechnol J.,2020; 18: 3361\u20133367. doi: 10.1016\/j.csbj.2020.10.038.","DOI":"10.1016\/j.csbj.2020.10.038"},{"key":"637131r9","doi-asserted-by":"crossref","unstructured":"Efron B.: Bootstrap Methods: Another Look at the Jackknife. In: Breakthroughsin Statistics. Springer Series in Statistics, Eds.: S. Kotz, N.L. Johnson.Springer, New York 1992.","DOI":"10.1007\/978-1-4612-4380-9_41"},{"key":"637131r10","doi-asserted-by":"crossref","unstructured":"Schiess E., Jensen K.H., Kristensen M.H. et al.: Epidemiology and treatmentoutcome of nasopharyngeal carcinoma in a low-incidence population \u2013 a DAHANCAanalysis in Denmark 2000-2018. Acta Oncol., 2024; 63: 850\u2013857. doi:10.2340\/1651-226X.2024.40499.","DOI":"10.2340\/1651-226X.2024.40499"},{"key":"637131r11","doi-asserted-by":"crossref","unstructured":"Pan J.J., Ng W.T., Zong J.F. et al.: Proposal for the 8th edition of the AJCC\/UICC staging system for nasopharyngeal cancer in the era of intensity-modulatedradiotherapy. Cancer., 2016; 122(4): 546\u2013558. doi: 10.1002\/cncr.29795.","DOI":"10.1002\/cncr.29795"},{"key":"637131r12","doi-asserted-by":"crossref","unstructured":"Rodrigues Dias D., Breda E., Sousa F., Soares A., Monteiro E.: Nasopharyngealcarcinoma in a non-endemic country-Validation of the new NPC staging system.Acta Otorrinolaringol Esp (Engl Ed)., 2023; 74(1): 39\u201349. doi: 10.1016\/j.otoeng.2022.04.001.","DOI":"10.1016\/j.otorri.2022.04.004"},{"key":"637131r13","doi-asserted-by":"crossref","unstructured":"Vijayvargiya P., Trivedi S., Rupji M. et al.: Comparison of the seventh and eighthedition of American Joint Committee on Cancer (AJCC) staging for selectedand nonselected oropharyngeal squamous cell carcinomas. Oncologist., 2022;27(1): 48\u201356. doi: 10.1093\/oncolo\/oyab001.","DOI":"10.1093\/oncolo\/oyab001"},{"key":"637131r14","doi-asserted-by":"crossref","unstructured":"Chang E.T., Ye W., Zeng Y.X., Adami H.O.: The evolving epidemiology of nasopharyngealcarcinoma. Cancer Epidemiol Biomarkers Prev., 2021; 30(6):1035\u20131047. doi: 10.1158\/1055-9965.EPI-20-1702.","DOI":"10.1158\/1055-9965.EPI-20-1702"},{"key":"637131r15","doi-asserted-by":"crossref","unstructured":"Ruuskanen M., Irjala H., Minn H. et al.: Epstein-Barr virus and human papillomavirusesas favorable prognostic factors in nasopharyngeal carcinoma: a nationwidestudy in Finland. Head Neck., 2019; 41(2): 349\u2013357. doi: 10.1002\/hed.25450.","DOI":"10.1002\/hed.25450"}],"container-title":["Otolaryngologia Polska"],"original-title":[],"link":[{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.6383","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/otolaryngologypl.com\/gicid\/pdf\/01.3001.0055.6383","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:54:23Z","timestamp":1778835263000},"score":1,"resource":{"primary":{"URL":"https:\/\/otolaryngologypl.com\/gicid\/01.3001.0055.6383"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,20]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3,3]]}},"URL":"https:\/\/doi.org\/10.5604\/01.3001.0055.6383","relation":{},"ISSN":["0030-6657","2300-8423"],"issn-type":[{"value":"0030-6657","type":"print"},{"value":"2300-8423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,20]]}}}